Wuhan Keqian Biology Co.,Ltd (688526.SS)
CNY 16.04
(0.19%)
CNY 16.04
(0.19%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 459.13 Million CNY | 3.49% |
| 2022 | 466.71 Million CNY | -29.39% |
| 2021 | 661 Million CNY | 26.07% |
| 2020 | 524.31 Million CNY | 87.89% |
| 2019 | 279.05 Million CNY | -38.25% |
| 2018 | 451.9 Million CNY | 20.01% |
| 2017 | 376.54 Million CNY | 79.36% |
| 2016 | 209.94 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 123.91 Million CNY | 165.81% |
| 2024 Q1 | 100.62 Million CNY | 130.07% |
| 2024 Q2 | 46.61 Million CNY | -53.67% |
| 2023 Q4 | -334.65 Million CNY | -345.97% |
| 2023 FY | 483.01 Million CNY | 3.49% |
| 2023 Q3 | 136.05 Million CNY | 14.52% |
| 2023 Q2 | 118.8 Million CNY | -24.76% |
| 2023 Q1 | 157.88 Million CNY | 9.71% |
| 2022 FY | 466.71 Million CNY | -29.39% |
| 2022 Q3 | 143.67 Million CNY | 88.17% |
| 2022 Q2 | 76.35 Million CNY | -25.7% |
| 2022 Q1 | 102.76 Million CNY | -52.15% |
| 2022 Q4 | 143.91 Million CNY | 0.17% |
| 2021 Q2 | 137.54 Million CNY | -29.26% |
| 2021 Q1 | 194.45 Million CNY | 28.22% |
| 2021 FY | 661 Million CNY | 26.07% |
| 2021 Q4 | 214.76 Million CNY | 87.99% |
| 2021 Q3 | 114.23 Million CNY | -16.95% |
| 2020 FY | 524.31 Million CNY | 87.89% |
| 2020 Q4 | 151.65 Million CNY | -4.46% |
| 2020 Q1 | 108.5 Million CNY | 95.99% |
| 2020 Q2 | 105.41 Million CNY | -2.84% |
| 2020 Q3 | 158.73 Million CNY | 50.57% |
| 2019 Q2 | 73.62 Million CNY | -3.62% |
| 2019 Q1 | 76.39 Million CNY | 0.0% |
| 2019 Q4 | 55.36 Million CNY | 20.96% |
| 2019 Q3 | 45.77 Million CNY | -37.84% |
| 2019 FY | 279.05 Million CNY | -38.25% |
| 2018 FY | 451.9 Million CNY | 20.01% |
| 2017 FY | 376.54 Million CNY | 79.36% |
| 2016 FY | 209.94 Million CNY | 0.0% |